| NCT Number | NCT06380686 |
| Lead Sponsor | AIO-Studien-gGmbH
Collaborators: Merck Sharp & Dohme LLC |
| Conditions | Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Hypopharynx, Squamous Cell Carcinoma of the Larynx |
| Enrollment | 120 participants |
| Start Date | 2024-11-07 |
| Primary Completion | 2029-11 (estimated) |
| Study Completion | 2030-11 (estimated) |
| Updated on ClinicalTrials.gov | 2024-11-13 |